Meta’s AI spending concerns are overblown, according to Morgan Stanley, who sees potential for the stock to surge to $1,000.

Shares of Idaho Strategic Resources rose after the mining company released favorable soil sampling results from its Lemhi Pass rare-earth-elements project. The stock increased 13%, to $45.10, midday ...

Shares of Lantronix hit their highest point in 52 weeks after the company said it was selected for a collaboration with Trillium Engineering that would expand its presence in the drone and defense ...

SilverCape Investments, which holds about 12% of PetMed's outstanding shares, announced a preliminary, non-binding proposal for the company for $4 a share. SilverCape said the price would be funded ...

(NASDAQ: LGHL) ("LGHL" or the "Company"), a leading operator of an all-in-one trading platform, today announced the acquisition of 88.49 units of Bitcoin (BTC) in $8 million, following the closing of ...

Starton Holdings filed for an initial public offering, as it works to develop a treatment for blood cancers. The clinical-stage biotechnology company plans to offer about 6.7 million shares priced at ...

While gold, and every other market, bounced around as investors tried to figure out what the Federal Reserve is thinking, the precious metal is now “ending its correction phase as it breaks out of the ...

Today's stock-market moves have been defined by a rotation away from tech stocks and towards areas that have lagged the tech rally this year. The Dow Jones Industrial Average has rallied today, ...

Tensions between the U.S. and Venezuela have climbed after the U.S. seized a sanctioned tanker off the coast of Venezuela, ...

The Federal Reserve cut its target rate by 25 basis points yesterday, its third cut of the year. However, even as that rate goes down, Treasury yields remain stubbornly high. "The Fed has been cutting ...

Analyst Rystad Energy said Wednesday's Federal Reserve rate cut is unlikely to move oil markets, with supply and demand fundamentals continuing to dominate price direction. The Fed lowered its ...

Shares of Okyo Pharma were higher Thursday after the company reported favorable nerve-restoration data for its drug that treats neuropathic corneal pain. Shares climbed 15% to $2.32 and are up twofold ...